CCNEP
CNB FINANCIAL CORP/PA
$24.73
+0.06%
$732.6M
No data for this timeframe.
Vol
Market Cap$732.6M
Cap SizeSmall Cap
SEC Reports3
Recent Activity
Apr 20, 2026
SEC
CNB Financial Corporation filed an 8-K to disclose an investor presentation made at its 2026 Annual Meeting of Sharehold
8-K — Impact 3/10
Apr 20, 2026
SEC
CNB Financial reported Q1 2026 earnings of $0.88 per share, matching adjusted EPS from Q4 2025 ($0.87) despite a 1.3% de
8-K — Impact 4/10
Apr 14, 2026
SEC
CNB Financial Corporation declared a quarterly dividend of $0.4453125 per depositary share (CCNEP) on its Series A Prefe
8-K — Impact 2/10
Analyst Ratings
3Strong Buy
4Buy
3Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
3/10
CNB Financial Corporation filed an 8-K to disclose an investor presentation made at its 2026 Annual Meeting of Sharehold
Apr 20, 2026
NEUTRAL
8-K
4/10
CNB Financial reported Q1 2026 earnings of $0.88 per share, matching adjusted EPS from Q4 2025 ($0.87) despite a 1.3% de
Apr 20, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.0/10.
NEUTRAL
8-K
3/10
CNB Financial Corporation filed an 8-K to disclose an investor presentation made at its 2026 Annual
Apr 20, 2026
NEUTRAL
8-K
4/10
CNB Financial reported Q1 2026 earnings of $0.88 per share, matching adjusted EPS from Q4 2025 ($0.8
Apr 20, 2026
NEUTRAL
8-K
2/10
CNB Financial Corporation declared a quarterly dividend of $0.4453125 per depositary share (CCNEP) o
Apr 14, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 70% buy across 10 analysts — 3 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 42.7% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 14.0% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.3B | 24.6% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.3B | 6.2% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 4 | 3 | 0 | 0 | 70% | |
| May 1, 2026 | 3 | 4 | 2 | 0 | 0 | 78% | |
| Apr 1, 2026 | 3 | 4 | 2 | 0 | 0 | 78% | |
| Mar 1, 2026 | 3 | 4 | 2 | 0 | 0 | 78% | |
| Feb 1, 2026 | 3 | 3 | 2 | 0 | 0 | 75% | |
| Jan 1, 2026 | 4 | 3 | 2 | 0 | 0 | 78% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.